Early immunophenotypical evaluation of minimal residual disease in acute myeloid leukemia identifies different patient risk groups and may contribute to postinduction treatment stratification

  1. San Miguel, J.F.
  2. Vidriales, M.B.
  3. López-Berges, C.
  4. Díaz-Mediavilla, J.
  5. Gutiérrez, N.
  6. Cañizo, C.
  7. Ramos, F.
  8. Pérez, J.J.
  9. González, M.
  10. Orfao, A.
Zeitschrift:
Blood

ISSN: 0006-4971

Datum der Publikation: 2001

Ausgabe: 98

Nummer: 6

Seiten: 1746-1751

Art: Artikel

DOI: 10.1182/BLOOD.V98.6.1746 GOOGLE SCHOLAR lock_openOpen Access editor